News
If you are looking to protect yourself against high blood pressure or hypertension as you age, you need to be consistent with lifestyle changes like regular exercise and workouts starting from early ...
COVID-19 cases are rising in India, driven by new variants and affecting vulnerable groups. Effective mask use remains key, though not all masks are equal. Read on to find out which mask keeps you ...
A twice-yearly injection could revolutionize how high blood pressure is treated, offering a major breakthrough for millions ...
A modified DASH diet, tailored for individuals with type 2 diabetes, significantly lowers blood pressure, even for those ...
10h
ScienceAlert on MSNStudy Reveals How Much Exercise You Need Each Week to Control Blood PressureWhen it comes to exercising for heart's sake, you don't want to peak too early in life. Research suggests that if you want to ...
High blood pressure, also known as hypertension, is a common health concern that significantly increases the risk of heart ...
Insmed Incorporated (NASDAQ:INSM) is a New Jersey-based biopharmaceutical company that develops and markets therapies to ...
The first participant has been dosed in a Phase 1 trial testing F230 for the treatment of pulmonary arterial hypertension.
Hypertension continues to present as a significant global health challenge, contributing notably to cardiovascular disease morbidity and mortality rates, as ...
Hypertension treatment and the role of cortisol in cardio-renal-metabolic health were among the featured topics from this ...
The FDA has approved Widaplik (telmisartan, amlodipine and indapamide) for the treatment of hypertension, including as initial treatment, to lower blood pressure.
A spirited pro/con debate at ERA 2025 explores whether population-level albuminuria screening could improve early CKD detection, with feasibility, cost-effectiveness, and equity all weighed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results